The eighth edition of China's new coronary pneumonia diagnosis and treatment program was released

xinhua News Agency, Beijing, August 19 (Reporter Chen Cong) 19 from the National Health and Health
will learn that the General Office of the National Health And Wellness Commission, the Office of the State Administration of Traditional Chinese Medicine issued a "new coronavirus pneumonia diagnosis and treatment program (trial eighth edition)."Guo Yanhong,
National Health and Health
Will be the Inspector General of the Hospital Administration, said that in the process of revision and improvement of the treatment plan, on the one hand, we summarize clinical experience, on the other hand, constantly optimize the diagnosis and treatment measures, so that the diagnosis and treatment program can be more scientific, more accurate, more perfect, more comprehensive, better to improve the level of treatment of new coronary pneumonia to provide guidelines and standardized framework.
Specifically, in terms of epidemiological characteristics, the eighth edition of the diagnosis and treatment program clearly "the source of infection is mainly new coronavirus infection patients and asymptomatic infected persons, in the incubation period is contagious, within 5 days after the onset of the disease is more contagious", the source of infection and transmission of the expression further improved, while adding "contact with virus-contaminated items can also cause infection" expression.
In terms of treatment, the eighth edition of the treatment proposes "not recommended for the single use of Lopinevir/Litonave and libawelin, no recommendation for the use of hydroxychloroquine or the combination of azithromycin", while adding specific elements of "channel management" and "anticoagulant therapy" to the treatment of heavy and critical cases.